Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Privia Health Group Inc

Healthcare US PRVA

22.47USD
-0.83(3.56%)

Last update at 2026-03-10T20:00:00Z

Day Range

22.2523.30
LowHigh

52 Week Range

15.9229.42
LowHigh

Fundamentals

  • Previous Close 23.30
  • Market Cap2065.39M
  • Volume1025436
  • P/E Ratio115.40
  • Dividend Yield-%
  • EBITDA21.77M
  • Revenue TTM1686.70M
  • Revenue Per Share TTM14.34
  • Gross Profit TTM 134.78M
  • Diluted EPS TTM0.15

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -18.58000M -218.50600M 23.46M 9.15M -4.26500M
Minority interest 3.48M 2.42M -3.09600M -2.75600M -2.45700M
Net income -12.06400M -190.64900M 31.24M 8.24M -3.04400M
Selling general administrative 129.59M 255.88M 44.02M 41.83M 41.50M
Selling and marketing expenses 19.74M 22.75M 11.34M 9.16M 11.74M
Gross profit 134.78M 63.66M 82.58M 68.47M 56.46M
Reconciled depreciation 4.57M 2.46M 1.83M 1.43M 1.07M
Ebit -19.12200M -217.43600M 25.38M 16.06M 2.15M
Ebitda -14.55100M -214.97200M 27.22M 17.49M 3.23M
Depreciation and amortization 4.57M 2.46M 1.84M 1.43M 1.07M
Non operating income net other - - - - -
Operating income -19.12200M -217.43600M 25.38M 16.06M 2.15M
Other operating expenses 1375.78M 1183.66M 791.70M 770.30M 655.45M
Interest expense 0.54M 1.07M 1.92M 6.91M 6.42M
Tax provision -6.51600M -27.85700M -7.44100M 1.21M -0.07600M
Interest income - - - - -
Net interest income 0.54M -1.07000M -1.91700M -6.91000M -6.42000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -6.51600M -27.85700M -7.44100M 1.21M -0.07600M
Total revenue 1356.66M 966.22M 817.08M 786.36M 657.61M
Total operating expenses 153.90M 281.10M 57.20M 52.41M 54.30M
Cost of revenue 1221.88M 902.56M 734.49M 717.89M 601.15M
Total other income expense net 0.54M -1.07000M -1.91700M -6.91000M -6.42000M
Discontinued operations - - - - -
Net income from continuing ops -12.06400M -190.64900M 30.90M 7.95M -4.18900M
Net income applicable to common shares -8.58500M -188.23000M 31.24M 8.24M -3.04400M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 999.90M 792.81M 686.37M 328.97M 270.20M
Intangible assets 107.63M 57.39M 59.74M 5.98M 6.62M
Earning assets - - - - -
Other current assets 20.52M 14.37M 8.70M 6.33M 5.37M
Total liab 392.51M 273.76M 236.19M 185.32M 162.75M
Total stockholder equity 561.44M 499.09M 426.87M 146.75M 110.21M
Deferred long term liab - - - - 2.30M
Other current liab 383.91M 254.53M 140.71M 109.64M 83.38M
Common stock 1.18M 1.15M 1.08M 0.96M 0.96M
Capital stock 1.18M 1.15M 1.08M 0.96M 0.96M
Retained earnings -193.61400M -216.69300M -208.10800M -19.87800M -51.12200M
Other liab - 1.00M 3.00M 5.59M 7.80M
Good will 138.75M 126.94M 127.94M 118.66M 118.66M
Other assets - 45.05M 37.88M 9.43M 9.70M
Cash 389.51M 347.99M 320.58M 84.63M 46.89M
Cash and equivalents - - - - -
Total current liabilities 386.95M 264.27M 190.46M 146.94M 115.22M
Current deferred revenue -383.90900M - 43.01M 31.18M 27.94M
Net debt -381.22200M -336.48900M -274.07800M -50.97400M -3.78900M
Short term debt 3.04M 3.01M 3.77M 0.88M 3.38M
Short long term debt - - 0.88M 0.88M 3.38M
Short long term debt total 8.29M 11.50M 46.50M 33.66M 43.10M
Other stockholder equity 753.87M 714.64M 633.90M 165.67M 160.38M
Property plant equipment - 3.39M 14.14M 4.81M 5.62M
Total current assets 700.80M 551.96M 446.68M 190.08M 129.60M
Long term investments - - - - -
Net tangible assets - 314.77M 239.20M 22.11M -15.07300M
Short term investments - - - - -
Net receivables 290.77M 189.60M 117.40M 99.12M 77.34M
Long term debt - - 31.69M 32.78M 39.73M
Inventory 0.00000M - - - -
Accounts payable 383.91M 6.73M 2.97M 5.24M 0.53M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 19.95M 23.31M - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - -2.17300M -0.98400M
Additional paid in capital - - - - -
Common stock total equity - 1.15M 1.08M 0.96M 0.96M
Preferred stock total equity - - - - -
Retained earnings total equity - -216.69300M -208.10800M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 8.58M 4.68M 4.52M 4.47M 9.70M
Deferred long term asset charges - - - - -
Non current assets total 299.10M 240.85M 239.70M 138.88M 140.61M
Capital lease obligations 8.29M 11.50M 13.94M - -
Long term debt total - - 31.69M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.10400M -32.77500M -0.38000M -5.70900M -0.16500M
Change to liabilities 4.85M 1.26M 4.71M -4.14100M -0.98300M
Total cashflows from investing activities -0.10400M -32.77500M -0.38000M -5.70900M -0.16500M
Net borrowings -33.25000M -0.87500M -0.87500M -10.25000M 15.25M
Total cash from financing activities -19.67700M 213.66M -0.76700M -10.86800M 15.36M
Change to operating activities 59.00M 31.35M 30.44M 24.05M 7.20M
Net income -12.06400M -190.64900M 30.90M 7.95M -4.18900M
Change in cash 27.41M 235.94M 37.74M 7.78M 20.44M
Begin period cash flow 320.58M 84.63M 46.89M 39.11M 18.67M
End period cash flow 347.99M 320.58M 84.63M 46.89M 39.11M
Total cash from operating activities 47.20M 55.06M 38.89M 24.36M 5.25M
Issuance of capital stock 0.00000M 223.69M - 0.00000M -
Depreciation 4.57M 2.46M 1.83M 1.43M 1.07M
Other cashflows from investing activities - -32.22800M - - -
Dividends paid - - - - -
Change to inventory - -1.26200M - - -
Change to account receivables -72.20200M -14.64200M -21.77900M -6.17800M 0.32M
Sale purchase of stock 13.57M 214.82M - - -
Other cashflows from financing activities 13.57M -9.14900M 10.11M 34.38M 15.36M
Change to netincome 60.35M 222.70M -7.69000M 0.62M 0.54M
Capital expenditures 0.10M 0.55M 0.38M 5.71M 0.22M
Change receivables -72.20200M -14.64200M - - -
Cash flows other operating 61.68M 37.04M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes 27.41M 235.94M - - -
Change in working capital -6.35300M 17.97M 13.37M 13.73M 6.54M
Stock based compensation 67.36M 253.53M 0.48M 0.21M 1.94M
Other non cash items 0.69M 0.16M 0.13M 0.33M 0.15M
Free cash flow 47.09M 54.51M 38.51M 18.65M 5.03M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PRVA
Privia Health Group Inc		 -0.83 3.56% 22.47 115.40 74.07 1.33 3.92 1.10 66.91
GEHC
GE HealthCare Technologies Inc.		 -2.9 3.83% 72.73 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -5.88 3.01% 189.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 11.42 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.07 1.34% 5.17 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Privia Health Group Inc

950 North Glebe Road, Arlington, VA, United States, 22203

Key Executives

Name Title Year Born
Mr. Matthew Shawn Morris CEO & Director 1964
Mr. Parth Mehrotra Pres & COO 1979
Mr. Thomas Bartrum Exec. VP & Gen. Counsel 1967
Mr. David Mountcastle CPA, MBA Exec. VP, CFO & Principal Accounting Officer 1971
Mr. Chris Voigt Exec. VP & Chief Technology Officer NA
Mr. Robert P. Borchert Sr. VP of Investor Relations & Corp. Communications NA
Ms. Dana Fields CPA Sr. VP of Internal Audit & Chief Compliance Officer NA
Ms. Jenny Harding Sr. VP of People Operations NA
Mr. Jay Stevens Sr. VP & Chief Growth Officer NA
Dr. Jim Sams M.D. CEO of Privia Medical Group - Georgia & Physician Exec. of Privia Medical Group - Tennessee NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.